Reneo Pharmaceuticals Inc (RPHM) Insider Trading
- $19,885,503.16
- $808,125.00
- Sept. 24, 2024
- Bali Muralidhar
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 24, 2024 | Major Shareholder | 29,600 | $1.41 | Buy | $41,736.00 | |
| Sept. 17, 2024 | Major Shareholder | 55,300 | $1.36 | Buy | $75,208.00 | |
| Aug. 13, 2024 | Major Shareholder | 171,339 | $1.39 | Buy | $238,161.21 | |
| May 14, 2024 | Major Shareholder | 414,281 | $1.54 | Buy | $637,992.74 | |
| Aug. 28, 2023 | Insider | 15,625 | $6.28 | Sell | $98,125.00 | |
| June 23, 2023 | Major Shareholder | 100,000 | $7.10 | Sell | $710,000.00 | |
| May 8, 2023 | Director | 125,000 | $8.00 | Buy | $1,000,000.00 | |
| Aug. 31, 2022 | COO | 3,212 | $3.21 | Buy | $10,310.52 | |
| Aug. 29, 2022 | COO | 83 | $3.24 | Buy | $268.92 | |
| Aug. 25, 2021 | CEO | 8,000 | $8.00 | Buy | $64,000.00 | |
| Aug. 25, 2021 | VP | 2,500 | $7.45 | Buy | $18,625.00 | |
| Aug. 25, 2021 | CFO | 5,000 | $7.44 | Buy | $37,200.00 | |
| July 14, 2021 | Director | 111,736 | $8.50 | Buy | $949,756.00 | |
| June 23, 2021 | Director | 20,710 | $9.28 | Buy | $192,188.80 | |
| June 21, 2021 | Director | 32,659 | $9.03 | Buy | $294,910.77 | |
| June 8, 2021 | Director | 16,605 | $9.50 | Buy | $157,747.50 | |
| June 3, 2021 | Director | 12,100 | $9.25 | Buy | $111,925.00 | |
| May 26, 2021 | Director | 5,915 | $9.38 | Buy | $55,482.70 | |
| April 13, 2021 | Major Shareholder | 666,666 | $15.00 | Buy | $9,999,990.00 | |
| April 13, 2021 | Director | 200,000 | $15.00 | Buy | $3,000,000.00 | |
| April 9, 2021 | Major Shareholder | 200,000 | $15.00 | Buy | $3,000,000.00 |
Insiders are both buying and selling Reneo Pharmaceuticals Inc stock.
The insider traders at Reneo Pharmaceuticals Inc are: Bali Muralidhar, Braden Michael Leonard, Michael Cruse, Niall O'donnell, Holdings A/S Novo, Vineet R Jindal, Gregory J Flesher, Venture Fund Iii L Rivervest, and Ashley Hall
The most active insider trader at Reneo Pharmaceuticals Inc is Bali Muralidhar with 6 trades.
Holdings A/S Novo has sold the most Reneo Pharmaceuticals Inc stock with a total value of $1,420,000.00.
Holdings A/S Novo has bought the most Reneo Pharmaceuticals Inc stock with a total value of $19,999,980.00.
The most recent insider trade for Reneo Pharmaceuticals Inc was on Sept. 24, 2024.
The single biggest insider buy for Reneo Pharmaceuticals Inc was from Holdings A/S Novo with a total value of $9,999,990.00 on April 13, 2021.
The single biggest insider sell for Reneo Pharmaceuticals Inc was from Holdings A/S Novo with a total value of $710,000.00 on June 23, 2023.